APA

Batliwalla F. M., Bateman B. A., Serrano D., Murray D., Macphail S., Maino V. C., Ansel J. C., Gregersen P. K. & Armstrong C. A. (19991005). A 15-year follow-up of AJCC stage III malignant melanoma patients treated postsurgically with Newcastle disease virus (NDV) oncolysate and determination of alterations in the CD8 T cell repertoire. : Molecular medicine (Cambridge, Mass.).

Chicago

Batliwalla F M, Bateman B A, Serrano D, Murray D, Macphail S, Maino V C, Ansel J C, Gregersen P K and Armstrong C A. 19991005. A 15-year follow-up of AJCC stage III malignant melanoma patients treated postsurgically with Newcastle disease virus (NDV) oncolysate and determination of alterations in the CD8 T cell repertoire. : Molecular medicine (Cambridge, Mass.).

Harvard

Batliwalla F. M., Bateman B. A., Serrano D., Murray D., Macphail S., Maino V. C., Ansel J. C., Gregersen P. K. and Armstrong C. A. (19991005). A 15-year follow-up of AJCC stage III malignant melanoma patients treated postsurgically with Newcastle disease virus (NDV) oncolysate and determination of alterations in the CD8 T cell repertoire. : Molecular medicine (Cambridge, Mass.).

MLA

Batliwalla F M, Bateman B A, Serrano D, Murray D, Macphail S, Maino V C, Ansel J C, Gregersen P K and Armstrong C A. A 15-year follow-up of AJCC stage III malignant melanoma patients treated postsurgically with Newcastle disease virus (NDV) oncolysate and determination of alterations in the CD8 T cell repertoire. : Molecular medicine (Cambridge, Mass.). 19991005.